I. Albanese

发表

Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

I. Albanese, A. Schwertani, 2015 .

Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease

H. Kindi, I. Albanese, A. Schwertani, 2014, Peptides.

Role of Noncanonical Wnt Signaling Pathway in Human Aortic Valve Calcification

J. Tardif, D. Shum-Tim, É. Rhéaume, 2017, Arteriosclerosis, thrombosis, and vascular biology.

A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells

P. Gros, J. C. Petrov, A. Nijnik, 2017, Immunology.

Atherosclerotic Calcification: Wnt Is the Hint

I. Albanese, A. Schwertani, K. Khan, 2018, Journal of the American Heart Association.

UROTENSIN II, UROTENSIN-RELATED PEPTIDE AND THEIR RECEPTOR IN AORTIC VALVE STENOSIS

R. Cecere, I. Albanese, A. Schwertani, 2018, Canadian Journal of Cardiology.

The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification

S. Daskalopoulou, A. Alsheikh-Ali, J. Genest, 2016, Front. Pharmacol..

Combined Central Hypothyroidism and Adrenal Insufficiency Associated with Retinoic Acid Therapy for Cutaneous T-Cell Lymphoma

I. G. Fantus, I. Albanese, A. Marino, 2022, AACE clinical case reports.

Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

J. Tardif, M. Cerutti, I. Albanese, 2019, The Journal of thoracic and cardiovascular surgery.

Still Asseembling Parts - The barriers to personalized genetics for pain management

I. Albanese, 2019, Health Science Inquiry.

A Case Report of Hyperestrogenism in Prader-Willi Syndrome

I. Albanese, N. Garfield, 2021, AACE clinical case reports.